Predicting who is at high risk for a heart attack or death may be as simple as obtaining a person's coronary artery calcium ...

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions.

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

XRF offers rapid, accurate elemental analysis for pharmaceuticals, detecting impurities and verifying ingredient quality with minimal sample preparation.

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

It's that time of year when students are waiting for school and university results that could change the course of their ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The Company’s lead program, SPC-15, is an intranasal treatment targeting ...

How well do you understand English? Which exam should you study for? This test contains grammar and vocabulary questions and your test result will help you choose a level to practise at. You will not ...